Rotterdam, Oct. 09, 2025 (GLOBE NEWSWIRE) — Today, celebrations are commencing worldwide for the second annual Youth Climate Adaptation Action Day (12th October), an initiative launched by the Global Center on Adaptation (GCA). From GCA’s Floating Office in Rotterdam to communities across more than 100 countries, young people will come together to consult on their […]
Press Releases
eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market
First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market BELLINGHAM, Wash., Oct. 08, 2025 (GLOBE NEWSWIRE) — eXp Realty®, the largest independent real estate brokerage in the world and a core subsidiary […]
eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market
eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market Leave a reply First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market First-of-its-kind platform brings residential and commercial under one […]
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by […]
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer Leave a reply Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments […]